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A Nasogastric Tube Inserted into the 
Gastrocutaneous Fistula
Yang Soo Kim, M.D., Joon Sung Kim, M.D., In Hee Yu, M.D., Ji Young Jeong, M.D., 
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We reported a case in which a nasogastric tube was inserted into the gastrocutaneous fistula, diagnosed by 
abdominal computed tomography. A 78-year-old man with a history of recurrent cerebral hemorrhage had a 
percutaneous endoscopic gastrostomy tube due to dysphagia for 2 years. However, soft tissue infection at the 
gastrostomy site caused the removal of the tube. Immediately, antibiotic agents were infused. For appropriate 
hydration and medication, a nasogastric tube was inserted. However, there was no significant improvement of 
the soft tissue infection. Moreover, the amount of bloody exudate increased. Abdominal computed tomography 
revealed the nasogastric tube placed under the patient’s skin via gastrocutaneous fistula. The nasogastric tube 
was removed, and an antibiotic agents were maintained. After 3 weeks, the signs of infection fully improved, 
and percutaneous endoscopic gastrostomy was performed again. Th   is case shows necessities of an appropriate 
interval between removal of the gastrostomy tube and insertion of a nasogastric tube, and suspicion of existence 
of gastrocutaneous fi  stula.
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INTRODUCTION
  Dysphagia from stroke can cause delays in the patient 
func  tional outcomes, and is reported as the primary 
cause of various medical complications such as aspira-
tion pneumonia, affecting approximately 25-45% of 
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patients.
1 Penington et al. also reported that subclinical 
lary  ngeal aspiration occurs in 40-60% of patients with 
dysphagic stroke.
2
  In patients with dysphagic stoke, nasogastric tube 
feeding is comparatively easy for nutritional support in 
initial stroke, can incur the patient uneasiness, is prone 
to being dislodged, and can cause aspiration pneumonia 
from mechanical obstruction. Percutaneous endoscopic 
gastrostomy, on the other hand, is comparatively simple 
to perform, has fewer side eff  ects, and provides cosmetic 
advantage. It is thus recommended for patients with long-
term dysphagic stroke to have percutaneous endoscopic 
gastrostomy if there is no gastrointestinal lesion.
3
  However, when performing percutaneous endoscopic 
gastrostomy, side effects can occur such as bleeding, 
gastric ulcer, intestinal perforation, or penetration A Nasogastric Tube Inserted into the Gastrocutaneous Fistula
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through the left lobe of the liver. Besides, it is inevitable 
that it needs to be removed after the operation for various 
reasons, most commonly infection. According to Pien 
et al., 4.8% of patients had infection after percutaneous 
endoscopic gastrostomy.
4 In cases of infection caused 
by gastrostomy tube, the tube was usually removed 
and antibiotic therapy was applied, and a nasogastric 
tube was inserted for nutritional support, hydration 
and smooth drug administration. We report the first 
case in which for a patient with long-term nutrition 
via gastrostomy tube, terminal portion of nasogastric 
tube was inserted through gastrocutaneous fistula after 
removal of the gastrostomy tube due to infection.
CASE REPORT
  A 78-year-old male patient was diagnosed as hyper-
tension and on medication came to our hospital after 
having a hematoma evacuation in an American hos-
pital because of left thalamic hemorrhage and right 
hemiplegia. In the computed tomography (CT) of his 
brain after hospitalization, intracerebral hemorrhage 
in the left frontal lobe and intraventricular hemorrhage 
were discovered. This led to operating hematoma 
evacuation, and a month later, ventriculoperitoneal 
shunt was installed because of hydrocephalus. Two 
months later, he was transferred to the rehabilitation 
medicine department for comprehensive rehabilitation. 
In the neurological examination at the time of transfer, 
his conscious state was maintained, but conversation 
was impossible and verbal responses were not observed 
due to the tracheostomy. He was already diagnosed as 
dysphagia at the time of hospitalization in the U.S. and 
had percutaneous endoscopic gastrostomy. When he was 
transferred to our hospital, he was still having nutrition 
support through the percutaneous gastrostomic tube. 
A month later, soft tissue infection occurred around the 
tube, so ceftriaxone was applied for antibiotic therapy, 
and the tube was replaced after the inflammation was 
relieved while the existing passage of gastrostomic tube 
was maintained. In the videofluoroscopic swallowing 
study carried out a month later, aspiration was still found 
so the gastrostomic tube was maintained, which led 
to the same result when the test was carried out three 
months later. Due to the malfunction of the gastrostomic 
tube a month later, the tube was replaced with the 
passage maintained, but was inserted again because 
the tube was dislodged during sleep two weeks after the 
replacement. In the videofl  uoroscopic swallowing study 
carried out 4 months later, aspiration still continued 
with decreased amount, and intermittent spontaneous 
swallowing activities were observed. However, we 
decided to maintain the tube and replaced it due to 
dysfunction. Three months after the replacement, the 
erythema and exudate containing blood clots were 
observed on the skin around the tube insertion (Fig. 1). 
In the blood test, the infectious signs were found with 
white blood cells 12,700/ul, segment neutrophils 76.6%, 
erythrocyte sedimentation rate 73 mm/h, and C-reactive 
protein 17.12 mg/dl, while body temperature was 
maintained under 37
oC. Urinalysis and urinary chemistry 
was not specific, bowel sounds was normal, but 
abdominal tenderness and rebound tenderness could not 
be examined due to the patient’s cognitive dysfunction. 
No anomalies were seen in the plain X-ray of chest and 
abdomen. Since infection in the gastrostomic tube 
insertion site was suspected, the tube was removed after 
microbiological culture. Ceftriaxone was applied for the 
purpose of empirical antibiotic therapy, and peripheral 
parenteral nutrition was initiated. The nasogastric 
tube was inserted the next day for the medication of 
hypertension, and was confi  rmed to have been located at 
the epigastrium by auscultation. Th   e nasogastric tube was 
used only for medication. Ceftriaxone was maintained 
because Klebsiella pneumoniae sensitive to β-Lactam 
Fig. 1. Erythematous skin is observed in the gastrostomy site 
after removal of tube.Yang Soo Kim, et al.
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antibiotics was identifi  ed. Th   ree days after removing the 
percutaneous gastrostomic tube and starting antibiotic 
therapy, the blood test became normal, but the erythema 
around the part of the tube insertion and the exudate 
containing blood clot did not improve. Since complex 
infection of anaerobes was suspected, metronidazole 
was orally administered. At the same time, CT was 
performed 4 days after the nasogastric tube insertion 
because of possible subcutaneous and intraperitoneal 
abscess. The abscess was not found by CT, but the 
terminal portion of the nasogastric tube penetrated the 
gastric mucous membrane and was located beneath 
the skin through the gastrocutaneous fistula with soft 
tissue infection around the gastrocutaneous fistula 
(Fig. 2). We thus diagnosed it as skin infection by the 
mislocation of the terminal portion of the nasogastric 
tube, removed the tube, administered 2 g of ceftriaxone 
and 1,500 mg of metronidazole daily, and inserted 
a central venous catheter for the purpose of total 
parenteral nutrition. Twenty days later, the skin around 
the removed gastrostomic tube was found to be normal, 
blood test was normal, and no indurate nodules were 
observed. Percutaneous endoscopic gastrostomy was 
thus performed on the spot 5 cm away from where the 
previous gastrostomic tube was inserted. No additional 
complication was observed.
DISCUSSION
  Even though nasogastric tube insertion is a compara-
tively easy operation, various problems can occur such 
Fig. 2. CT fi  ndings show a transverse 
cut (A) and a coronal cut (B) of 
nasogastric tube placed beneath the 
skin via gastrocutaneous fi  stula.
as esophageal laceration during insertion, mislocation, 
metabolic disorder, and dehydration. After nasogastric 
tube insertion, there are many ways to confirm the 
location of the terminal portion: to make the patient 
use their voice, to perform suction of gastric content, 
to auscultate air bubbles, and to perform plain chest 
X-ray. Neither of these, however, can verify the correct 
location of the nasogastric tube inside of the stomach 
wall.
5 Among mislocations of the nasogastric tube, the 
intubation to the respiratory system is most frequent 
because the terminal tube cannot be inspected by 
eye during insertion. Most cases are intubation to the 
trachea, but some reports are on pneumothorax through 
the lungs.
6 Some are a large quantity of aspiration caused 
by the terminal tube located in the pharyngeal airway 
and esophagus, or within the intracranial penetration 
through the ethmoid bone. Wynne et al. also reported a 
nasogastric tube located in the Eustachian canal.
5,7
  After performing percutaneous endoscopic gastrostomy, 
it is common for it to be placed for a long time unless 
there is any complication like infection or tubal 
dysfunction. However, in case of removing a gastrostomic 
tube, gastrocutaneous fistula can remain, which is 
naturally closed after a few hours or days. Therefore, 
2-44% of patients with gastrocutaneous fistula are 
reported to remain for more than a week. It mostly occurs 
when the tube is placed for as long as 9-11 months, and 
is also related to delayed stomach emptying, foreign 
body within the stomach such as silk suture, chronic 
granulomatous disease or Crohn’s disease.
8 Some reports 
show gastrocutaneous fistula continuing a month after A Nasogastric Tube Inserted into the Gastrocutaneous Fistula
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removing the gastrostomic tube. Kobak et al. reported 
that it was closed at 53% using argon plasma coagulation 
and H2 antagonist.
9 Therapeutic endoscopy could also 
be applied, with the defect of the tissue sutured using the 
clip.
10
  Patients with percutaneous gastrostomic tubes 
often need to remove the tube because of infection or 
accidents. In many cases, nasogastric tubes are inserted 
for orally administered medication, whereas short-term 
nutrition supply can be through the vessel. However, it 
cannot be applied clinically in general to delaying the 
nasogastric tube insertion bearing in mind the existing 
gastrocutaenous fistula, so nasogastric tube is usually 
inserted 24 hours after removing the gastrostomic tube 
when there is no particular problem. In this case report, 
the nasogastric tube was also inserted one day after 
removing the gastrostomic tube, in order to confirm its 
location, auscultation and suction of gastric contents. 
However, we could not find evidence of the nasogastric 
tube invading the gastrocutaenous fistula. Even though 
confi  rming the nasogastric tube through abdomen X-ray 
tells the running status within the alimentary canal, 
gastrocutaenous fistula usually occurs vertically to the 
direction of the alimentary canal, making it difficult 
to confirm the locations of the nasogastric tube and 
gastrocutaneous fistula by two-dimensional X-ray. 
In addition, through lateral abdominal plain x-ray, 
it is also difficult to catch the shade of the terminal 
portion of the nasogastric tube because of abdominal 
organs. Considering that the terminal nasogastric tube 
is observed to be located in gastrocutaenous fistula 
with soft tissue infection 4 days after the insertion, the 
possible transition of the tube from gastric fundus to 
gastrocutaneous fi  stula by peristalsis cannot be excluded.
 The gastrostomic tube needs to be removed after 
percutaneous endoscopic gastrostomy for many reasons. 
Th   is is particularly the case when it is removed because 
of infection, secretion and erythema are involved where 
the tube is removed, making it hard to precisely estimate 
the existence of gastrocutaneous fi  stula. Moreover, when 
the nasogastric tube is inserted into gastrocutaneous 
fi  stula, its location cannot be examined exactly by simple 
physical examination or chest plain X-ray. The case of 
the nasogastric tube locating in the gastrocutaneous 
fistula and causing soft tissue infection is not common. 
It is important to check the existence of remaining 
gastrocutaneous fi  stula, in case there is no improvement 
in spite of proper antibiotic therapy as seen in this 
case study. It is also important to closely observe the 
existence of gastrocutaneous fistula when removing 
the percutaneous gastrostomic tube and inserting the 
nasogastric tube.
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